Purchase Order 140D0426P0288
Award Date 8/17/26
Potential Completion Date 10/16/26
Potential Value $49K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Auburn, CA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Cancer Institute awarded a purchase order to Miltenyi Biotec, Inc. for $42,863.50 on September 20, 2019, for the AutoMACS Pro Separator HCL and HCLV leukemic cells sorting system. Performance location is Auburn, California. The order, issued on firm fixed-price terms under a special notice posting, carries an ultimate completion date of December 20, 2019. No set-aside applies.</p>
- The National Cancer Institute (NCI) awarded a $55,190.00 firm-fixed-price purchase order contract to Miltenyi Biotec, Inc. for the procurement of one Miltenyi Biotec autoMACS NEO Separator and MACS MiniSampler S. This equipment will support the Clinical Immunotherapy Section of the Laboratory of Molecular Biology at the NCI's Center for Cancer Research. The contract has an ultimate completion date of September 30, 2024 and was awarded on July 1, 2024. This purchase order was not set aside for...
- <p>The National Cancer Institute awarded a purchase order to Miltenyi Biotec, Inc., valued at $25,881.00, on September 15, 2020, for one GentleMACS Octo Dissociator with heaters. The order carries a firm fixed price and is due for completion by October 15, 2020. Place of performance is Auburn, California. The procurement originated from a solicitation posted August 17, 2020, and due August 24, 2020, with no small business set-aside applied.</p>
- The National Cancer Institute awarded a purchase order to Miltenyi Biotec, Inc., for a GentleMACS Octo Dissociator with heaters, valued at $21,688.50, on August 14, 2019, with completion by September 15, 2019. The equipment will be delivered to Auburn, California. This is a firm fixed-price, non-competitive acquisition reflecting the vendor's position as a specialized sole-source supplier of automated tissue dissociation instruments and related laboratory equipment to the federal research...
- <p>The National Cancer Institute awarded a purchase order to Miltenyi Biotec, Inc. for a full-service maintenance agreement covering an AutoMACS Pro Separator (serial #160-001-254) valued at $5,559.00, with an award date of October 31, 2017. The agreement covers service from November 1, 2017 through October 31, 2018, with quarterly payment terms. Work is performed at Hickstein Lab in Bethesda, Maryland. No set-aside was used on this firm fixed-price procurement.</p>
- <p>The National Cancer Institute awarded a purchase order to Miltenyi Biotec, Inc. for $24,980.62 on July 27, 2020, for scientific equipment with an ultimate completion date of August 31, 2020. No set-aside was used. Performance occurs in Auburn, California. The order procures specialized biotechnology equipment and reagents for cell separation, analysis, and processing technologies that support biomedical research and cell therapy development. Pricing is firm fixed price.</p>
- <p>The National Cancer Institute awarded a purchase order to Miltenyi Biotec, Inc. for a GentleMACS Octo Dissociator with heaters valued at $21,688.50 on April 2, 2019. Performance of the firm fixed-price order was completed by June 3, 2019. Work was performed in Auburn, California.</p>
- <p>The National Cancer Institute awarded a purchase order to Miltenyi Biotec, Inc. valued at $20,907.00 on August 14, 2018, with ultimate completion on August 13, 2019. Work is performed in Auburn, California. The order is firm fixed-price with no set-aside applied. Specific requirements are not detailed in the source material.</p>
- <p>The National Cancer Institute awarded a purchase order to Miltenyi Biotec, Inc. for a GentleMACS Octo Dissociator with heaters (catalog #130-096-427) valued at $20,907.00, awarded August 8, 2018, with completion by September 30, 2018. Performance occurs in Bethesda, Maryland. The order is firm fixed-price with no set-aside.</p>
- <p>The National Cancer Institute awarded a purchase order to Miltenyi Biotec, Inc. for a GentleMACS Octo Dissociator with heater (catalog #130-096-427) on July 24, 2018, with a ceiling value of $23,550.00 and firm fixed-price terms. Place of performance is Bethesda, Maryland. The order is set to complete by September 30, 2018.</p>